Transplantation Therapies from Human Embryonic Stem Cells—Circumventing Immune Rejection
- 7 March 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in E-Biomed: The Journal of Regenerative Medicine
- Vol. 1 (1) , 11-15
- https://doi.org/10.1089/152489000414525
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The Future of Organ and Tissue TransplantationJAMA, 1999
- COMBINED HISTOCOMPATIBILITY LEUKOCYTE ANTIGENMATCHED DONOR BONE MARROW AND RENAL TRANSPLANTATION FOR MULTIPLE MYELOMA WITH END STAGE RENAL DISEASE: THE INDUCTION OF ALLOGRAFT TOLERANCE THROUGH MIXED LYMPHOHEMATOPOIETIC CHIMERISMTransplantation, 1999
- Mixed chimerism: Preclinical studies and clinical applicationsTransplantation and Cellular Therapy, 1999
- Putting Stem Cells to WorkScience, 1999
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- Transposon-generated ‘knock-out’ and ‘knock-in’ gene-targeting constructs for use in miceCurrent Biology, 1997
- Viable offspring derived from fetal and adult mammalian cellsNature, 1997
- The lost chord: microchimerism and allograft survivalImmunology Today, 1996
- Isolation of a primate embryonic stem cell line.Proceedings of the National Academy of Sciences, 1995
- Mice lacking major histocompatibility complex class I and class II molecules.Proceedings of the National Academy of Sciences, 1993